C. Tropé

1.8k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

C. Tropé is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, C. Tropé has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 4 papers in Surgery. Recurrent topics in C. Tropé's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). C. Tropé is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). C. Tropé collaborates with scholars based in Norway, Sweden and Switzerland. C. Tropé's co-authors include Gunnar B. Kristensen, Delaloye Jf, Mahesh Parmar, Andreas du Bois, Jonathan A. Ledermann, Sarah Wheeler, Gordon C. Jayson, Valter Torri, Nicoletta Colombo and Alan Lamont and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gynecologic Oncology.

In The Last Decade

C. Tropé

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

2003 885 citations Mahesh Parmar, Jonathan A. Ledermann et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Tropé Norway	9	947	492	392	391	136	13	1.2k
Delaloye Jf Switzerland	3	735 0.8×	422 0.9×	281 0.7×	346 0.9×	104 0.8×	8	935
S. Pecorelli Italy	4	895 0.9×	456 0.9×	460 1.2×	284 0.7×	107 0.8×	4	1.2k
Eizo Kimura Japan	11	754 0.8×	394 0.8×	290 0.7×	370 0.9×	122 0.9×	20	1.1k
Anderley Gordon United States	10	923 1.0×	581 1.2×	308 0.8×	536 1.4×	139 1.0×	32	1.3k
Abbie L. Fields United States	19	454 0.5×	325 0.7×	488 1.2×	318 0.8×	113 0.8×	43	1.2k
J. J. Kavanagh United States	17	545 0.6×	303 0.6×	232 0.6×	396 1.0×	181 1.3×	50	1.2k
M. Gropp Germany	10	570 0.6×	346 0.7×	232 0.6×	232 0.6×	90 0.7×	23	766
Henric Malmström Sweden	14	1.2k 1.3×	721 1.5×	799 2.0×	478 1.2×	287 2.1×	30	1.8k
Masamichi Hiura Japan	16	705 0.7×	251 0.5×	750 1.9×	198 0.5×	97 0.7×	50	1.2k
Lawrence R. Nycum United States	11	1.1k 1.2×	352 0.7×	281 0.7×	687 1.8×	186 1.4×	26	1.4k

Countries citing papers authored by C. Tropé

Since Specialization

Citations

This map shows the geographic impact of C. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tropé more than expected).

Fields of papers citing papers by C. Tropé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tropé. The network helps show where C. Tropé may publish in the future.

Co-authorship network of co-authors of C. Tropé

This figure shows the co-authorship network connecting the top 25 collaborators of C. Tropé. A scholar is included among the top collaborators of C. Tropé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Tropé. C. Tropé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tian, Wenjuan, Dongmei Chi, Jalid Sehouli, et al.. (2011). A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: An evidence-based proposal for patient selection.. Journal of Clinical Oncology. 29(15_suppl). 5053–5053. 2 indexed citations

Sandstad, Berit, et al.. (2011). The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome.. PubMed. 32(4). 369–76. 2 indexed citations

Vergote, Ignace, C. Tropé, Frédéric Amant, et al.. (2008). EORTC-GcG/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA). 46 indexed citations

Parmar, Mahesh, Jonathan A. Ledermann, Nicoletta Colombo, et al.. (2003). Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. The Lancet. 361(9375). 2099–2106. 885 indexed citations breakdown →

Tropé, C., et al.. (2000). Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide.. PubMed. 21(3). 255–9. 2 indexed citations

Tropé, C., J. Kærn, Ignace Vergote, Gunnar B. Kristensen, & Vera M. Abeler. (1993). Are Borderline Tumors of the Ovary Overtreated both Surgically and Systemically? A Review of Four Prospective Randomized Trials Including 253 Patients with Borderline Tumors. Gynecologic Oncology. 51(2). 236–243. 67 indexed citations

Wïllén, Roger, A. Himmelmann, Mårten Fernö, et al.. (1993). Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.. PubMed. 13(4). 1187–96. 9 indexed citations

Kjørstad, Knut E., et al.. (1993). Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985. International Journal of Gynecological Cancer. 3(2). 110–115. 20 indexed citations

Makar, Amin, Gunnar B. Kristensen, J. Kærn, et al.. (1993). Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: New aspects and multivariate analysis. International Journal of Gynecology & Obstetrics. 40(2). 182–183. 82 indexed citations

10.

Bye, Asta, et al.. (1992). The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy. Clinical Nutrition. 11(3). 147–153. 22 indexed citations

11.

Kærn, J., C. Tropé, & Vera M. Abeler. (1990). A PHASE II STUDY OF 5-FU/ CIS IN RECURRENT CERVICAL CANCER. 29. 25–28. 1 indexed citations

12.

Lindahl, B, et al.. (1987). Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.. PubMed. 7(4B). 781–9. 28 indexed citations

13.

Grundsell, Hans, et al.. (1979). Prognosis of adenocarcinoma of the uterine cervix. Gynecologic Oncology. 8(2). 204–208. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact